Your browser doesn't support javascript.
loading
Recurrent GNAQ mutation encoding T96S in natural killer/T cell lymphoma.
Li, Zhaoming; Zhang, Xudong; Xue, Weili; Zhang, Yanjie; Li, Chaoping; Song, Yue; Mei, Mei; Lu, Lisha; Wang, Yingjun; Zhou, Zhiyuan; Jin, Mengyuan; Bian, Yangyang; Zhang, Lei; Wang, Xinhua; Li, Ling; Li, Xin; Fu, Xiaorui; Sun, Zhenchang; Wu, Jingjing; Nan, Feifei; Chang, Yu; Yan, Jiaqin; Yu, Hui; Feng, Xiaoyan; Wang, Guannan; Zhang, Dandan; Fu, Xuefei; Zhang, Yuan; Young, Ken H; Li, Wencai; Zhang, Mingzhi.
Affiliation
  • Li Z; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, 450052, Zhengzhou, China.
  • Zhang X; Lymphoma Diagnosis and Treatment Center of Henan Province, 450000, Zhengzhou, China.
  • Xue W; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, 450052, Zhengzhou, China.
  • Zhang Y; Lymphoma Diagnosis and Treatment Center of Henan Province, 450000, Zhengzhou, China.
  • Li C; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, 450052, Zhengzhou, China.
  • Song Y; Institute of Clinical Medicine, The First Affiliated Hospital of Zhengzhou University, 450052, Zhengzhou, China.
  • Mei M; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, 450052, Zhengzhou, China.
  • Lu L; Institute of Clinical Medicine, The First Affiliated Hospital of Zhengzhou University, 450052, Zhengzhou, China.
  • Wang Y; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, 450052, Zhengzhou, China.
  • Zhou Z; Institute of Clinical Medicine, The First Affiliated Hospital of Zhengzhou University, 450052, Zhengzhou, China.
  • Jin M; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, 450052, Zhengzhou, China.
  • Bian Y; Institute of Clinical Medicine, The First Affiliated Hospital of Zhengzhou University, 450052, Zhengzhou, China.
  • Zhang L; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, 450052, Zhengzhou, China.
  • Wang X; Institute of Clinical Medicine, The First Affiliated Hospital of Zhengzhou University, 450052, Zhengzhou, China.
  • Li L; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, 450052, Zhengzhou, China.
  • Li X; Institute of Clinical Medicine, The First Affiliated Hospital of Zhengzhou University, 450052, Zhengzhou, China.
  • Fu X; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, 450052, Zhengzhou, China.
  • Sun Z; Institute of Clinical Medicine, The First Affiliated Hospital of Zhengzhou University, 450052, Zhengzhou, China.
  • Wu J; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, 450052, Zhengzhou, China.
  • Nan F; Institute of Clinical Medicine, The First Affiliated Hospital of Zhengzhou University, 450052, Zhengzhou, China.
  • Chang Y; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, 450052, Zhengzhou, China.
  • Yan J; Institute of Clinical Medicine, The First Affiliated Hospital of Zhengzhou University, 450052, Zhengzhou, China.
  • Yu H; Medical Research Centre, The First Affiliated Hospital of Zhengzhou University, 450052, Zhengzhou, China.
  • Feng X; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, 450052, Zhengzhou, China.
  • Wang G; Lymphoma Diagnosis and Treatment Center of Henan Province, 450000, Zhengzhou, China.
  • Zhang D; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, 450052, Zhengzhou, China.
  • Fu X; Lymphoma Diagnosis and Treatment Center of Henan Province, 450000, Zhengzhou, China.
  • Zhang Y; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, 450052, Zhengzhou, China.
  • Young KH; Lymphoma Diagnosis and Treatment Center of Henan Province, 450000, Zhengzhou, China.
  • Li W; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, 450052, Zhengzhou, China.
  • Zhang M; Lymphoma Diagnosis and Treatment Center of Henan Province, 450000, Zhengzhou, China.
Nat Commun ; 10(1): 4209, 2019 09 16.
Article in En | MEDLINE | ID: mdl-31527657
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, T-Cell / Mutation, Missense / GTP-Binding Protein alpha Subunits, Gq-G11 Type of study: Risk_factors_studies Limits: Animals / Female / Humans / Male Language: En Journal: Nat Commun Journal subject: BIOLOGIA / CIENCIA Year: 2019 Document type: Article Affiliation country: China Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, T-Cell / Mutation, Missense / GTP-Binding Protein alpha Subunits, Gq-G11 Type of study: Risk_factors_studies Limits: Animals / Female / Humans / Male Language: En Journal: Nat Commun Journal subject: BIOLOGIA / CIENCIA Year: 2019 Document type: Article Affiliation country: China Country of publication: Reino Unido